News
Echolight official partner of PRECCO
Echolight becomes a partner of PRECCO, the consortium born from the collaboration between ESCEO, IOF and the World Health Organization for the...
New certification for Echolight
Echolight obtains ISO environmental certification, our contribution to a sustainable future In August 2022, Echolight S.P.A. has also achieved the...
HTA Study on REMS
SDA Bocconi University: REMS helps cut NHS costs According to the HTA independent research conducted by the lecturers Patrizio Armeni and...
New Headquarters in New York
New USA headquarters and new certifications New York, May 13, 2022: We are pleased to announce the move of our new USA Headquarters to the...
Echolight & Aurora Spine
Aurora Spine Corporation Announces Co-Marketing Agreement for its DEXA Platform with Echolight Medical CARLSBAD, Calif., Feb. 24, 2022 (GLOBE...
New quality standard
Echolight is pleased to announce that a new process to improve the company organization has been successfully completed, this time aimed at...
REMS in the guidelines
R.E.M.S. IN NATIONAL GUIDELINES New important recognition for Echolight: REMS technology (Radiofrequency Echographic Multi Spectrometry), the first...
Echolight awarded Vizient
Echolight Medical awarded Vizient contract to provide improved technology in bone density diagnostics. Echolight Medical, an innovator in bone...
Echolight in India
Echolight in India We are pleased to announce that Echolight officially lands in India thanks to the signing of a commercial agreement with an...
Prediction of Fragility Fractures
Use of the Fragility Score measured at the femoral neck for the prediction of fragility incident fractures. F.A. Lombardi, P. Pisani, D. Ciardo, M....
Echolight S.p.a.
Viale Cipro, 6
73100 Lecce – Italy
+39 0832 159 26 07
US Headquarters
509 Madison Ave RM 1510
New York, New York 10022, USA
Copyright © 2021 - Echolight S.p.a
